Cystic Fibrosis (CF) is the most common life-threatening genetic disorder affecting Australian children.
CF affects all parts of the body, but mainly damages the lungs and digestive system. Over time, the lungs become increasingly affected by inflammation and respiratory function is significantly reduced. There are a number of treatments available to reduce the problems caused by the condition, but average life expectancy is ultimately compromised. At present there is no cure.
Sydney Children's Hospitals Network has research centres at both major paediatric hospitals, the miCF Research Centre at Sydney Children's Hospital, Randwick, and the Respiratory Medicine Research group at The Children's Hospital at Westmead.
Our researchers are actively involved in CF research and clinical trials, testing the safety and efficacy of novel therapies and interventions for CF, as well as investigating how CF affects the respiratory, digestive and endocrine systems.
Through our research in these areas we aim to find a cure for CF.
